[1]
Osman, D. et al. 2025. Venetoclax-Azacitidine Salvage Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Single-Center Experience. Journal of Hematology. 14, 2 (Apr. 2025), 105–108. DOI:https://doi.org/10.14740/jh1362.